Target Audience and Goal Statement
This activity is intended for heart failure specialists, electrophysiologists, general cardiologists, internists, critical
care specialists, nurses, nurse practitioners, and physician assistants who care for patients at risk for sudden cardiac death.
The goal of this activity is to update clinicians' awareness of management techniques to address the risks of decompensation
and sudden cardiac arrest in patients with heart failure.
Upon completion of this activity, participants will be able to:
- Analyze how decompensation and/or sudden cardiac arrest affect heart failure morbidity and mortality
- Review management techniques aimed at preventing decompensation and sudden cardiac arrest in patients with heart failure
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Author(s)

-
Clyde W. Yancy, MD
Magerstadt Professor of Medicine, Chief of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
Disclosures
Disclosure: Clyde W. Yancy, MD, has disclosed no relevant financial relationships.
Dr Yancy does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Yancy does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

-
William T. Abraham, MD
Professor of Internal Medicine; Director, Division of Cardiovascular Medicine; Deputy Director, Davis Heart and Lung Research
Institute, The Ohio State University, Columbus, Ohio
Disclosures
Disclosure: William T. Abraham, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories; BIOTRONIK; Medtronic, Inc.; Novartis Pharmaceuticals Corporation;
Respicardia, Inc.; St. Jude Medical; Sunshine Heart, Inc.; Zoll Medical Corporation
Dr Abraham does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Abraham does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

-
Anne B. Curtis, MD
Charles and Mary Bauer Professor and Chair, Department of Medicine, University at Buffalo, Buffalo, New York; President and
CEO, UBMD Internal Medicine, Amherst, New York
Disclosures
Disclosure: Anne B. Curtis, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Biosense Webster, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Medtronic,
Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Sanofi; St. Jude Medical; Pfizer Inc
Served as a speaker or a member of a speakers bureau for: Medtronic, Inc.; St. Jude Medical
Dr Curtis does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Curtis does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
Editor
Steering Committee
-
Deepak L. Bhatt, MD, MPH
Chief of Cardiology, VA Boston Healthcare System; Senior Physician, Brigham and Women's Hospital; Professor of Medicine, Harvard
Medical School; Senior Investigator, TIMI Study Group, Boston, Massachusetts
Disclosures
Disclosure: Deepak L. Bhatt, MD, MPH, has disclosed the following relevant financial relationships:
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Eisai Inc.; Ethicon,
Inc.; Medtronic, Inc.; sanofi-aventis; The Medicines Company; Medtronic, Inc.
-
Roberta C. Bogaev, MD
Assistant Professor of Medicine, Baylor College of Medicine, Houston, Texas; Private Practice Cardiologist, Schnitzler Cardiovascular
Consultants, San Antonio, Texas
Disclosures
Disclosure: Roberta C. Bogaev, MD Roberta C. Bogaev, MD, has disclosed no relevant financial relationships.
-
Jagmeet P. Singh, MD, PhD
Associate Professor of Medicine, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center, Harvard Medical
School, Boston, Massachusetts
Disclosures
Disclosure: Jagmeet P. Singh, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BIOTRONIK; Boston Scientific; Medtronic, Inc.; St. Jude Medical; Sorin Group; CardioInsight
Technologies Inc.; Thoratec Corporation
Served as a speaker or a member of a speakers bureau for: BIOTRONIK; Boston Scientific; St. Jude Medical; Sorin Group
Received grants for clinical research from: BIOTRONIK; Boston Scientific; St. Jude Medical; Sorin Group; Medtronic, Inc.
CME Reviewer(s)
-
Laurie E. Scudder, DNP, NP
Clinical Editor, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing
and Allied Health, George Washington University, Washington, DC
Disclosures
Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.
Accreditation Statements
For Physicians
-
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
Medscape, LLC designates this enduring material for a maximum of 0.5
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Contact This Provider
For Nurses
-
Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission
on Accreditation.
Awarded 0.5 contact hour(s) of continuing nursing education for RNs and APNs; 0.0 contact hours are in the area of pharmacology.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.